Addex Therapeutics Capital Expenditures (CapEx) Growth & History (ADXN)

Addex Therapeutics's capital expenditures (capex) was CHF1,273 for fiscal 2024.

View full Addex Therapeutics company overview

Addex Therapeutics annual capital expenditures (capex) history

Addex Therapeutics annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20242024-12-31CHF1,273−CHF5,569−81.39%
20232023-12-31CHF6,842CHF6,261+1077.62%
20222022-12-31CHF581−CHF30,968−98.16%
20212021-12-31CHF31,549−CHF27,865−46.90%
20202020-12-31CHF59,414CHF30,955+108.77%
20192019-12-31CHF28,459CHF19,405+214.33%
20182018-12-31CHF9,054CHF8,357+1199.00%
20172017-12-31CHF697

Addex Therapeutics capital expenditures (capex) trends

Over the last five fiscal years, Addex Therapeutics's capital expenditures (capex) decreased from CHF28,459 to CHF1,273, a change of −CHF27,186. The latest reported quarter, Q2 2025, shows CHF0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Addex Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about ADXN yet. Start the conversation.

Write the first post